Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Evaluation of Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancreas Cancer (Baylor University Medical Center and Texas Oncology Experience)

NCT01771146 is registered in ClinicalTrials.gov with Baylor Research Institute as lead sponsor.

NCT NCT01771146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01771146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Evaluation of Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancreas Cancer (Baylor University Medical Center and Texas Oncology Experience)
Lead sponsor
Baylor Research Institute
Phase
Not applicable
Overall status
Unknown status
Start date
October 31, 2012
Completion date
September 30, 2020
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

localized pancreas cancer, non-metastatic pancreas cancer, pancreas cancer